Semaglutide is a prescription medication approved by the FDA for the treatment of type 2 diabetes mellitus and chronic weight management in adults with obesity or overweight with weight-related comorbidities
Buchwalow, I., Samoilova, V., Boecker, W
A post-hoc analysis of the SURMOUNT-1 trial found that patients achieving the greatest triglyceride reductions also showed the largest improvements in hs-CRP (high-sensitivity C-reactive protein), a marker of systemic inflammation linked to atherosclerosis
The typical compounded formulation uses pyridoxine at a concentration of 50 mg/mL
Rescue of Munc18-1 and -2 double knockdown reveals the essential functions of interaction between Munc18 and closed syntaxin in PC12 cells
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes (NCT07321886)